Prasugrel achieves greater and faster P2Y12 receptor–mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease - Wallentin, L; Varenhorst, C; James, S (Eur Heart J, 2008)